These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1739986)
1. Mechanisms involved in NK resistance induced by interferon-gamma. Ramirez R; Solana R; Carracedo J; Alonso MC; Peña J Cell Immunol; 1992 Mar; 140(1):248-56. PubMed ID: 1739986 [TBL] [Abstract][Full Text] [Related]
2. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. Uchida A; Vánky F; Klein E J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505 [TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
4. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Mizutani Y; Bonavida B; Nio Y; Yoshida O Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609 [TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D. Uchida A; Klein E Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288 [TBL] [Abstract][Full Text] [Related]
6. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392 [TBL] [Abstract][Full Text] [Related]
7. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433 [TBL] [Abstract][Full Text] [Related]
8. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect]. Zhang C; Tian Z; Hou G Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763 [TBL] [Abstract][Full Text] [Related]
9. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328 [TBL] [Abstract][Full Text] [Related]
10. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis. Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892 [TBL] [Abstract][Full Text] [Related]
11. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579 [TBL] [Abstract][Full Text] [Related]
13. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF). Marubayashi M; Solana R; Ramirez R; Aranda E; Galan F; Peña J Br J Cancer; 1991 Jun; 63(6):893-6. PubMed ID: 1906292 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507 [TBL] [Abstract][Full Text] [Related]
15. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes. Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276 [TBL] [Abstract][Full Text] [Related]
16. MHC class I expression on human tumour cells and their susceptibility to NK lysis. Pena J; Solana R; Alonso MC; Santamaria M; Serrano R; Ramirez R; Carracedo J J Immunogenet; 1989; 16(4-5):407-12. PubMed ID: 2517951 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells. Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960 [TBL] [Abstract][Full Text] [Related]
18. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity. Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines. Wright SC; Bonavida B J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]